Intracrine FFA4 signaling controls lipolysis at lipid droplets.

Saved in:
Bibliographic Details
Title: Intracrine FFA4 signaling controls lipolysis at lipid droplets.
Authors: O'Brien SL; Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK. s.l.obrien@bham.ac.uk.; Centre of Membrane Proteins and Receptors (COMPARE), Universities of Nottingham and Birmingham, Birmingham, UK. s.l.obrien@bham.ac.uk., Tripp E; Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Centre of Membrane Proteins and Receptors (COMPARE), Universities of Nottingham and Birmingham, Birmingham, UK., Barki N; Centre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Blondel-Tepaz E; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Quebec, Canada.; Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada., Smith G; Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK., Boufersaoui A; Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK., Roberts J; Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK., Pike JA; Centre of Membrane Proteins and Receptors (COMPARE), Universities of Nottingham and Birmingham, Birmingham, UK., Correia J; Centre of Membrane Proteins and Receptors (COMPARE), Universities of Nottingham and Birmingham, Birmingham, UK., Miljus T; Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Centre of Membrane Proteins and Receptors (COMPARE), Universities of Nottingham and Birmingham, Birmingham, UK., Bouvier M; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Quebec, Canada.; Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada., Tennant DA; Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK., Hudson BD; Centre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Gerhart-Hines Z; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark., Milligan G; Centre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Schwartz TW; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark., Calebiro D; Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK. d.calebiro@bham.ac.uk.; Centre of Membrane Proteins and Receptors (COMPARE), Universities of Nottingham and Birmingham, Birmingham, UK. d.calebiro@bham.ac.uk.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK. d.calebiro@bham.ac.uk.
Source: Nature chemical biology [Nat Chem Biol] 2026 Jan; Vol. 22 (1), pp. 109-119. Date of Electronic Publication: 2025 Aug 05.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101231976 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4469 (Electronic) Linking ISSN: 15524450 NLM ISO Abbreviation: Nat Chem Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1552-4469
DOI:10.1038/s41589-025-01982-5